Cholinergic anti-inflammatory pathway confers airway protection against oxidative damage and attenuates inflammation in an allergic asthma model. 2020

Géssica Luana Antunes, and Josiane Silva Silveira, and Daniela Benvenutti Kaiber, and Carolina Luft, and Mariana Severo da Costa, and Eduardo Peil Marques, and Fernanda Silva Ferreira, and Ricardo Vaz Breda, and Angela T S Wyse, and Renato Tetelbom Stein, and Paulo Márcio Pitrez, and Aline Andrea da Cunha
Laboratory of Pediatric Respirology, Infant Center, School of Medical, Pontifícia Universidade Católica do Rio Grande do Sul, PUCRS, Porto Alegre, Brazil.

Asthma is characterized by the influx of inflammatory cells, especially of eosinophils as well as reactive oxygen species (ROS) production, driven by the release of the T helper 2 (Th2)-cell-associated cytokines. The cholinergic anti-inflammatory pathway (CAP) inhibit cytokines production and controls inflammation. Thus, we investigated the effects of pharmacological activation of CAP by neostigmine on oxidative stress and airway inflammation in an allergic asthma model. After the OVA challenge, mice were treated with neostigmine. We showed that CAP activation by neostigmine reduced the levels of pro-inflammatory cytokines (IL-4, IL-5, IL-13, IL-1β, and TNF-α), which resulted in a decrease of eosinophils influx. Furthermore, neostigmine also conferred airway protection against oxidative stress, attenuating ROS production through the increase of antioxidant defense, evidenced by the catalase (CAT) activity. We propose, for the first time, that pharmacological activation of the CAP can lead to new possibilities in the therapeutic management of allergic asthma.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009388 Neostigmine A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. Synstigmin,Neostigmine Bromide,Neostigmine Methylsulfate,Polstigmine,Proserine,Prostigmin,Prostigmine,Prozerin,Syntostigmine,Bromide, Neostigmine,Methylsulfate, Neostigmine
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D015213 Neuroimmunomodulation The biochemical and electrophysiological interactions between the NERVOUS SYSTEM and IMMUNE SYSTEM. Cholinergic Anti-inflammatory Pathway,Neuro-immune Axis,Neuro-immune Communication,Neuro-immune Interactions,Neuro-immunomodulation,Neuroimmune Axis,Neuroimmune Communication,Neuroimmune Interactions,Neuroimmune Processes,Vagal Anti-inflammatory Pathway,Vagal-immune Interactions,Neuroimmune Mechanisms,Neuroimmune Process,Anti-inflammatory Pathway, Cholinergic,Anti-inflammatory Pathway, Vagal,Cholinergic Anti inflammatory Pathway,Cholinergic Anti-inflammatory Pathways,Communication, Neuro-immune,Communication, Neuroimmune,Interaction, Neuro-immune,Interaction, Neuroimmune,Mechanism, Neuroimmune,Neuro immune Axis,Neuro immune Communication,Neuro immune Interactions,Neuro immunomodulation,Neuro-immune Communications,Neuro-immune Interaction,Neuroimmune Communications,Neuroimmune Interaction,Neuroimmune Mechanism,Process, Neuroimmune,Vagal Anti inflammatory Pathway,Vagal Anti-inflammatory Pathways,Vagal immune Interactions,Vagal-immune Interaction
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Géssica Luana Antunes, and Josiane Silva Silveira, and Daniela Benvenutti Kaiber, and Carolina Luft, and Mariana Severo da Costa, and Eduardo Peil Marques, and Fernanda Silva Ferreira, and Ricardo Vaz Breda, and Angela T S Wyse, and Renato Tetelbom Stein, and Paulo Márcio Pitrez, and Aline Andrea da Cunha
September 2016, International immunopharmacology,
Géssica Luana Antunes, and Josiane Silva Silveira, and Daniela Benvenutti Kaiber, and Carolina Luft, and Mariana Severo da Costa, and Eduardo Peil Marques, and Fernanda Silva Ferreira, and Ricardo Vaz Breda, and Angela T S Wyse, and Renato Tetelbom Stein, and Paulo Márcio Pitrez, and Aline Andrea da Cunha
August 2009, Chest,
Géssica Luana Antunes, and Josiane Silva Silveira, and Daniela Benvenutti Kaiber, and Carolina Luft, and Mariana Severo da Costa, and Eduardo Peil Marques, and Fernanda Silva Ferreira, and Ricardo Vaz Breda, and Angela T S Wyse, and Renato Tetelbom Stein, and Paulo Márcio Pitrez, and Aline Andrea da Cunha
November 2021, BMC pulmonary medicine,
Géssica Luana Antunes, and Josiane Silva Silveira, and Daniela Benvenutti Kaiber, and Carolina Luft, and Mariana Severo da Costa, and Eduardo Peil Marques, and Fernanda Silva Ferreira, and Ricardo Vaz Breda, and Angela T S Wyse, and Renato Tetelbom Stein, and Paulo Márcio Pitrez, and Aline Andrea da Cunha
January 2009, Journal of Zhejiang University. Science. B,
Géssica Luana Antunes, and Josiane Silva Silveira, and Daniela Benvenutti Kaiber, and Carolina Luft, and Mariana Severo da Costa, and Eduardo Peil Marques, and Fernanda Silva Ferreira, and Ricardo Vaz Breda, and Angela T S Wyse, and Renato Tetelbom Stein, and Paulo Márcio Pitrez, and Aline Andrea da Cunha
January 2015, Inflammation,
Géssica Luana Antunes, and Josiane Silva Silveira, and Daniela Benvenutti Kaiber, and Carolina Luft, and Mariana Severo da Costa, and Eduardo Peil Marques, and Fernanda Silva Ferreira, and Ricardo Vaz Breda, and Angela T S Wyse, and Renato Tetelbom Stein, and Paulo Márcio Pitrez, and Aline Andrea da Cunha
March 2003, Journal of immunology (Baltimore, Md. : 1950),
Géssica Luana Antunes, and Josiane Silva Silveira, and Daniela Benvenutti Kaiber, and Carolina Luft, and Mariana Severo da Costa, and Eduardo Peil Marques, and Fernanda Silva Ferreira, and Ricardo Vaz Breda, and Angela T S Wyse, and Renato Tetelbom Stein, and Paulo Márcio Pitrez, and Aline Andrea da Cunha
January 2023, Molecular medicine reports,
Géssica Luana Antunes, and Josiane Silva Silveira, and Daniela Benvenutti Kaiber, and Carolina Luft, and Mariana Severo da Costa, and Eduardo Peil Marques, and Fernanda Silva Ferreira, and Ricardo Vaz Breda, and Angela T S Wyse, and Renato Tetelbom Stein, and Paulo Márcio Pitrez, and Aline Andrea da Cunha
January 2024, Cellular signalling,
Géssica Luana Antunes, and Josiane Silva Silveira, and Daniela Benvenutti Kaiber, and Carolina Luft, and Mariana Severo da Costa, and Eduardo Peil Marques, and Fernanda Silva Ferreira, and Ricardo Vaz Breda, and Angela T S Wyse, and Renato Tetelbom Stein, and Paulo Márcio Pitrez, and Aline Andrea da Cunha
January 2012, International immunopharmacology,
Géssica Luana Antunes, and Josiane Silva Silveira, and Daniela Benvenutti Kaiber, and Carolina Luft, and Mariana Severo da Costa, and Eduardo Peil Marques, and Fernanda Silva Ferreira, and Ricardo Vaz Breda, and Angela T S Wyse, and Renato Tetelbom Stein, and Paulo Márcio Pitrez, and Aline Andrea da Cunha
January 2010, Biological & pharmaceutical bulletin,
Copied contents to your clipboard!